Taisho Pharmaceutical's operating profit FY 2013 to 2018
In the fiscal year 2018, Taisho Pharmaceutical Holdings Co., Ltd. recorded an operating profit amounting to approximately 31 billion Japanese yen, a decrease from around 37 billion Japanese yen in the previous fiscal year. The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.